Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320593 · ClinicalTrials.gov registry record · Phase 3
Correction of Myopia Evaluation Trial 2
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 118
- Enrollment target
NCT00320593 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 118 participants.
The verdict
NCT00320593, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 118 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.
Interventions
- DEVICE Single Vision Lenses (SVLs)
- DEVICE Progressive Addition Lenses (PALs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2005-04 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320593
The ClinicalTrials.gov registry entry for NCT00320593 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Single Vision Lenses (SVLs) is the first listed.
NCT00320593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320593 about?
NCT00320593 is a clinical study titled "Correction of Myopia Evaluation Trial 2". The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.
What is the current status of trial NCT00320593?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 118 participants. The study started on 2005-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00320593?
The interventions under investigation include: Single Vision Lenses (SVLs) (DEVICE), Progressive Addition Lenses (PALs) (DEVICE).
Who is sponsoring clinical trial NCT00320593?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.